Komori
The Toho Bank (8346) · RiskMaterialised

Equity price, interest rate and foreign exchange risks relating to securities

First written in FY2017. 17 of 24 entries say "Materialised", first in FY2019-Q3. Latest entry: FY2027-H1.

24entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017MaterialisedFY2019-Q3 – FY2023-Q3MitigatedFY2024 – FY2025-H1MaterialisedFY2026-H1 – FY2027-H12017: 120172018: 020182019: 420192020: 320202021: 420212022: 320222023: 320232024: 320242025: 120252026: 22026
Same theme, other companies
Market fluctuation risk in interest rates, foreign exchange rates and securities pricesA theme 39 companies write about · 39 as a headwind · 0 as a tailwind

The Toho Bank moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 15 of 26 companies on the "Worse" side.

7 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 39 companies compared. The sentences above are computed from all 39.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1MaterialisedAnnual report

    「Impairment losses during the interim consolidated accounting period amounted to ¥41 million, comprising ¥22 million on shares and ¥19 million on business bonds.」

    For securities on which no impairment losses were recognized in the previous fiscal year, impairment losses during the interim period totaled ¥41 million, comprising ¥22 million on equities and ¥19 million on business bonds.
  2. FY2026WorsenedAnnual report

    「The valuation difference on available-for-sale securities changed from negative ¥9,149 million in the previous consolidated fiscal year to negative ¥13,786 million in the current consolidated fiscal year.」

    While the negative valuation difference on securities widened, no securities impairment losses were recognized during the current consolidated fiscal year.
  3. FY2026-H1MaterialisedAnnual report

    「The amount of impairment losses recognized during the interim consolidated accounting period was ¥4 million, all of which related to shares.」

    For securities on which no impairment losses were recognized in the previous fiscal year, impairment losses of ¥4 million on equities arose during the interim period.
  4. FY2025-H1MitigatedAnnual report

    「No impairment losses were recognized during the interim consolidated accounting period.」

    No impairment losses on securities were recognized during the interim period. Meanwhile, the valuation difference on available-for-sale securities declined from ¥7,353 million at the end of the previous fiscal year to ¥5,791 million.
  5. FY2024MitigatedAnnual report

    「No impairment losses were recognized during the consolidated fiscal year.」

    The ¥1,307 million in securities impairment losses recognized in the previous fiscal year did not recur in the current fiscal year. The valuation difference on available-for-sale securities also improved from negative ¥1,283 million to ¥7,353 million.
  6. FY2024-Q3Improvement in securities valuation differences; no impairment lossesAnnual report

    「No impairment losses were recognized during the current third-quarter consolidated cumulative period.」

    No impairment losses on securities were recognized during the cumulative third quarter. In addition, the valuation difference on available-for-sale securities improved from negative ¥10,730 million in the same period of the previous year to positive ¥4,315 million.
  7. FY2024-Q2Deterioration in valuation differences on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities △ 6,165 △ 2,144」

    The valuation difference on available-for-sale securities improved from negative ¥6,165 million in the same interim period of the previous year to negative ¥2,144 million in the current interim period, while the balance on the consolidated balance sheet was negative ¥3,427 million. No impairment losses on securities were recognized during the interim period.
  8. FY2024-Q1Improvement in the valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities △ 2,996 4,280」

    The valuation difference on available-for-sale securities improved from negative ¥2,996 million in the same quarter of the previous year to positive ¥4,280 million in the first quarter.
  9. FY2023-Q3MaterialisedAnnual report

    「The amount of impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year was ¥1,509 million, comprising ¥1,479 million on shares and ¥30 million on corporate bonds.」

    In connection with market movements in securities, including share prices and interest rates, the company recognized ¥1,509 million in impairment losses during the cumulative third quarter.
  10. FY2023-Q2MaterialisedAnnual report

    「The amount of impairment losses recognized during the interim consolidated accounting period was ¥1,503 million, comprising ¥1,457 million on shares and ¥45 million on corporate bonds.」

    In connection with market movements in securities, including share prices and interest rates, the company recognized ¥1,503 million in impairment losses during the interim period, of which ¥1,457 million was on equities.
  11. FY2023-Q1MaterialisedAnnual report

    「Valuation difference on available-for-sale securities △ 2,996」

    In the first quarter, the valuation difference on available-for-sale securities was negative ¥2,996 million, reflecting a disclosed decline in valuation differences due to market movements in securities.
  12. FY2022-Q3MaterialisedAnnual report

    「The amount of impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year was ¥331 million, comprising ¥231 million on shares and ¥99 million on corporate bonds.」

    The company recognized total impairment losses of ¥331 million on securities affected by fluctuations in share prices, interest rates and other factors, including ¥231 million on equities and ¥99 million on corporate bonds.
  13. FY2022-Q2MaterialisedAnnual report

    「The amount of impairment losses recognized during the interim consolidated accounting period was ¥468 million, comprising ¥248 million on shares and ¥219 million on corporate bonds.」

    The company recognized impairment losses of ¥248 million on equities and ¥219 million on corporate bonds, totaling ¥468 million.
  14. FY2022-Q1MaterialisedAnnual report

    「Impairment losses on shares and other securities ¥2 million ¥402 million」

    The company recognized ¥402 million in write-downs of equities and other securities, with losses resulting from fluctuations in share prices and other factors continuing to appear in its results.
  15. FY2021MaterialisedAnnual report

    「Gains and losses on equities and other securities decreased by ¥1,554 million from the previous consolidated fiscal year to a loss of ¥1,994 million, as the company recognized losses on sales of equities and other securities resulting from the disposal of unrealized losses in rebuilding its securities portfolio to secure stable earnings capable of withstanding financial market volatility.」

    In response to market volatility, the company rebuilt its securities portfolio and recognized losses on sales of equities and other securities in connection with the disposal of unrealized losses. Securities impairment losses totaled ¥786 million.
  16. FY2021-Q3MaterialisedAnnual report

    「The amount of impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year was ¥497 million, all of which related to shares.」

    The company recognized ¥497 million in impairment losses on equities.
  17. FY2021-Q2MaterialisedAnnual report

    「The amount of impairment losses recognized during the interim consolidated accounting period was ¥64 million, all of which related to shares.」

    Impairment losses on securities associated with declines in equity prices and other factors amounted to ¥64 million during the interim period.
  18. FY2020MaterialisedAnnual report

    「As share prices fell sharply toward the end of the period, the company recognized impairment losses on its securities holdings, resulting in」

    The risk of falling share prices materialized as impairment losses on securities holdings, with securities impairment losses for the fiscal year totaling ¥1,326 million.
  19. FY2020-Q3MaterialisedAnnual report

    「The amount of impairment losses recognized during the cumulative third quarter of the current consolidated fiscal year was ¥602 million, comprising ¥423 million on shares, ¥149 million on corporate bonds and ¥28 million on other securities.」

    The company recognized total impairment losses of ¥602 million on equities, corporate bonds and other securities.
  20. FY2020-Q2MaterialisedAnnual report

    「The amount of impairment losses recognized during the interim consolidated accounting period was ¥371 million, comprising ¥244 million on shares, ¥99 million on corporate bonds and ¥27 million on other securities.」

    The company recognized total impairment losses of ¥371 million on equities, corporate bonds and other securities.
  21. FY2020-Q1MaterialisedAnnual report

    「The amount of impairment losses recognized during the cumulative first quarter of the current consolidated fiscal year was ¥480 million, comprising ¥230 million on shares and ¥249 million on corporate bonds.」

    In relation to fluctuations in share prices, interest rates and other factors affecting securities, the company recognized impairment losses of ¥230 million on equities and ¥249 million on corporate bonds.
  22. FY2019MaterialisedAnnual report

    「The impairment loss recognized during the consolidated fiscal year was ¥49 million, all on corporate bonds.」

    The company recognized ¥49 million in impairment losses on corporate bonds.
  23. FY2019-Q3MaterialisedAnnual report

    「The impairment loss recognized during the cumulative third quarter of the consolidated fiscal year was ¥123 million, comprising ¥99 million on corporate bonds and ¥23 million on other securities.」

    The company recognized ¥123 million in impairment losses on corporate bonds and other securities whose fair value had declined significantly below acquisition cost and was not expected to recover.
  24. FY2017First statedAnnual report

    「The bank holds marketable equities, and a decline in share prices could result in impairment losses or valuation losses on its holdings and adversely affect its results. The bank also holds marketable bonds, including government bonds, and if long-term interest rates rise and bond prices fall, valuation losses on its holdings could arise and adversely affect its results. Some of the securities held by the bank are affected by exchange-rate fluctuations.」

    The company classifies valuation losses and declines in the value of securities resulting from falling share prices, rising long-term interest rates and yen appreciation as market risks.
Moved together

"Balance management of risk management claims" moved the same way as this thread, in the same document, in 18 of its 24 moves.

18137333★123456
  1. ★This thread
  2. 1Balance management of risk management claims18×
  3. 2Increase in ordinary expenses due to higher credit-related costs13×
  4. 3Impairment risk from declines in fixed asset prices7×
  5. 4Dividend Payment and 75th Anniversary Commemorative Dividend3×
  6. 5Management of Credit Exposure from Undrawn Loan Commitments3×
  7. 6Low market interest rates under negative interest rates3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for The Toho Bank yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.